Jessica R. KIRSHNER

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 ant...
- Patent number 12,258,412
- Issue date Mar 25, 2025
- REGENERON PHARMACEUTICALS, INC.
- Eric Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors with BCMA specificity and uses thereof
- Patent number 12,150,959
- Issue date Nov 26, 2024
- REGENERON PHARMACEUTICALS, INC.
- David DiLillo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-human papillomavirus (HPV) antigen-binding proteins and method...
- Patent number 12,115,216
- Issue date Oct 15, 2024
- REGENERON PHARMACEUTICALS, INC.
- Kevin A. Bray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of bispecific antigen-binding molecules that bind MUC16 and CD3...
- Patent number 12,091,460
- Issue date Sep 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
- Patent number 11,905,332
- Issue date Feb 20, 2024
- REGENERON PHARMACEUTICALS, INC.
- David DiLillo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific an...
- Patent number 11,633,501
- Issue date Apr 25, 2023
- REGENERON PHARMACEUTICALS, INC.
- John Rudge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-EGFRvIII antibodies and uses thereof
- Patent number 11,608,380
- Issue date Mar 21, 2023
- REGENERON PHARMACEUTICALS, INC.
- Jessica R. Kirshner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-human papillomavirus (HPV) antigen-binding proteins and method...
- Patent number 11,559,576
- Issue date Jan 24, 2023
- Regeneran Pharmaceuticals, Inc.
- Kevin A. Bray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific ant...
- Patent number 11,485,793
- Issue date Nov 1, 2022
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Grant
Methods and antibody compositions for tumor treatment
- Patent number 11,434,300
- Issue date Sep 6, 2022
- REGENERON PHARMACEUTICALS, INC.
- Eric Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
- Patent number 11,384,153
- Issue date Jul 12, 2022
- Regeneran Pharmaceuticals, Inc.
- Eric Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...
- Patent number 11,155,633
- Issue date Oct 26, 2021
- Regeneran Pharmaceuticals, Inc.
- Jessica R. Kirshner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-MUC16 antibodies
- Patent number 10,941,208
- Issue date Mar 9, 2021
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Grant
Methods of treating PRLR positive breast cancer
- Patent number 10,925,971
- Issue date Feb 23, 2021
- REGENERON PHARMACEUTICALS, INC.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-human papillomavirus (HPV) antigen-binding proteins and method...
- Patent number 10,806,780
- Issue date Oct 20, 2020
- REGENERON PHARMACEUTICALS, INC.
- Kevin A. Bray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-STEAP2 antibody drug conjugates, and compositions and uses the...
- Patent number 10,772,972
- Issue date Sep 15, 2020
- REGENERON PHARMACEUTICALS, INC.
- John Rudge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antigen-binding molecules that bind MUC16 and CD3, and c...
- Patent number 10,738,130
- Issue date Aug 11, 2020
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Grant
Anti-EGFRvIII antibodies and uses thereof
- Patent number 10,738,124
- Issue date Aug 11, 2020
- REGENERON PHARMACEUTICALS, INC.
- Jessica R. Kirshner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody-drug conjugates comprising anti-prolactin receptor (PRLR)...
- Patent number 10,683,354
- Issue date Jun 16, 2020
- REGENERON PHARMACEUTICALS, INC.
- Nicholas J. Papadopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for tumor treatment using CD3XCD20 bispecific antibody
- Patent number 10,662,244
- Issue date May 26, 2020
- REGENERON PHARMACEUTICALS, INC.
- Eric Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and antibody compositions for tumor treatment
- Patent number 10,550,193
- Issue date Feb 4, 2020
- REGENERON PHARMACEUTICALS, INC.
- Eric Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...
- Patent number 10,179,819
- Issue date Jan 15, 2019
- REGENERON PHARMACEUTICALS, INC.
- Jessica R. Kirshner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antagonist antibodies to human prolactin receptor (PRLR)
- Patent number 10,106,616
- Issue date Oct 23, 2018
- REGENERON PHARMACEUTICALS, INC.
- Nicholas J. Papadopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-EGFRvIII antibodies and uses thereof
- Patent number 10,047,160
- Issue date Aug 14, 2018
- REGENERON PHARMACEUTICALS, INC.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating breast cancer by administering anti-human prola...
- Patent number 9,688,764
- Issue date Jun 27, 2017
- REGENERON PHARMACEUTICALS, INC.
- Nicholas J. Papadopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PRLR antibodies and methods for killing PRLR-expressing cells
- Patent number 9,545,451
- Issue date Jan 17, 2017
- REGENERON PHARMACEUTICALS, INC.
- Nicholas J. Papadopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-EGFRvIII antibodies and uses thereof
- Patent number 9,475,875
- Issue date Oct 25, 2016
- REGENERON PHARMACEUTICALS, INC.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PRLR antibodies and methods for killing PRLR-expressing cells
- Patent number 9,302,015
- Issue date Apr 5, 2016
- REGENERON PHARMACEUTICALS, INC.
- Nicholas J. Papadopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHOD...
- Publication number 20250064913
- Publication date Feb 27, 2025
- Regeneron Pharmaceuticals, Inc.
- Kevin A. Bray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3...
- Publication number 20250042999
- Publication date Feb 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof
- Publication number 20240325445
- Publication date Oct 3, 2024
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-EGFRvIII ANTIBODY DRUG CONJUGATES AND USES THEREOF
- Publication number 20240293566
- Publication date Sep 5, 2024
- Regeneron Pharmaceuticals, Inc.
- Frank DELFINO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF
- Publication number 20240158529
- Publication date May 16, 2024
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHOD...
- Publication number 20230270837
- Publication date Aug 31, 2023
- Regeneron Pharmaceuticals, Inc.
- Kevin A. Bray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20230272111
- Publication date Aug 31, 2023
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Antibody Compositions for Tumor Treatment
- Publication number 20230220101
- Publication date Jul 13, 2023
- Regeneron Pharmaceuticals, Inc.
- Eric Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof
- Publication number 20220306758
- Publication date Sep 29, 2022
- Regeneron Pharmaceuticals, Inc.
- Eric Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1) ANTIG...
- Publication number 20220251215
- Publication date Aug 11, 2022
- Regeneron Pharmaceuticals, Inc.
- Kevin A. Bray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF
- Publication number 20220089766
- Publication date Mar 24, 2022
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHOD...
- Publication number 20220001000
- Publication date Jan 6, 2022
- Regeneron Pharmaceuticals, Inc.
- Kevin A. Bray
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules That Bin...
- Publication number 20210403595
- Publication date Dec 30, 2021
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-EGFRVIII ANTIBODIES AND USES THEREOF
- Publication number 20210147557
- Publication date May 20, 2021
- Regeneron Pharmaceuticals, Inc.
- Jessica R. KIRSHNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3...
- Publication number 20200399371
- Publication date Dec 24, 2020
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND PSMA AND CD3...
- Publication number 20200399372
- Publication date Dec 24, 2020
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific An...
- Publication number 20200376136
- Publication date Dec 3, 2020
- Regeneron Pharmaceuticals, Inc.
- John Rudge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20200317810
- Publication date Oct 8, 2020
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Antibody Compositions for Tumor Treatment
- Publication number 20200115464
- Publication date Apr 16, 2020
- Regeneron Pharmaceuticals, Inc.
- Eric Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof
- Publication number 20200024356
- Publication date Jan 23, 2020
- Regeneron Pharmaceuticals, Inc.
- Eric Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof
- Publication number 20200023010
- Publication date Jan 23, 2020
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PRLR ANTIBODIES AND USES THEREOF
- Publication number 20190241667
- Publication date Aug 8, 2019
- Regeneron Pharmaceuticals, Inc.
- Nicholas J. PAPADOPOULOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules that Bin...
- Publication number 20190127480
- Publication date May 2, 2019
- Jessica R. Kirshner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHOD...
- Publication number 20190000956
- Publication date Jan 3, 2019
- Regeneron Pharmaceuticals, Inc.
- Kevin A. Bray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-EGFRvIII ANTIBODIES AND USES THEREOF
- Publication number 20180312594
- Publication date Nov 1, 2018
- Regeneron Pharmaceuticals, Inc.
- Jessica R. KIRSHNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TUMOR TREATMENT USING CD3XCD20 BISPECIFIC ANTIBODY
- Publication number 20180194841
- Publication date Jul 12, 2018
- Regeneron Pharmaceuticals, Inc.
- Eric Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING PRLR POSITIVE BREAST CANCER
- Publication number 20180185504
- Publication date Jul 5, 2018
- Regeneron Pharmaceuticals, Inc.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20180118848
- Publication date May 3, 2018
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20180112001
- Publication date Apr 26, 2018
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific An...
- Publication number 20180104357
- Publication date Apr 19, 2018
- Regeneron Pharmaceuticals, Inc.
- John Rudge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jessica R. KIRSHNER

Person

Patents Grantslast 30 patents

Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 ant...

Chimeric antigen receptors with BCMA specificity and uses thereof

Anti-human papillomavirus (HPV) antigen-binding proteins and method...

Use of bispecific antigen-binding molecules that bind MUC16 and CD3...

Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof

Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific an...

Anti-EGFRvIII antibodies and uses thereof

Anti-human papillomavirus (HPV) antigen-binding proteins and method...

Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific ant...

Methods and antibody compositions for tumor treatment

Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof

Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...

Anti-MUC16 antibodies

Methods of treating PRLR positive breast cancer

Anti-human papillomavirus (HPV) antigen-binding proteins and method...

Anti-STEAP2 antibody drug conjugates, and compositions and uses the...

Bispecific antigen-binding molecules that bind MUC16 and CD3, and c...

Anti-EGFRvIII antibodies and uses thereof

Antibody-drug conjugates comprising anti-prolactin receptor (PRLR)...

Methods for tumor treatment using CD3XCD20 bispecific antibody

Methods and antibody compositions for tumor treatment

Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...

Antagonist antibodies to human prolactin receptor (PRLR)

Anti-EGFRvIII antibodies and uses thereof

Methods of treating breast cancer by administering anti-human prola...

Anti-PRLR antibodies and methods for killing PRLR-expressing cells

Anti-EGFRvIII antibodies and uses thereof

Anti-PRLR antibodies and methods for killing PRLR-expressing cells

Patents Applicationslast 30 patents

ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHOD...

USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3...

Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof

ANTI-EGFRvIII ANTIBODY DRUG CONJUGATES AND USES THEREOF

ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF

ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHOD...

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

Methods and Antibody Compositions for Tumor Treatment

Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof

ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1) ANTIG...

ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF

ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHOD...

Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules That Bin...

ANTI-EGFRVIII ANTIBODIES AND USES THEREOF

USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3...

USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND PSMA AND CD3...

Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific An...

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

Methods and Antibody Compositions for Tumor Treatment

Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof

Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof

ANTI-PRLR ANTIBODIES AND USES THEREOF

Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules that Bin...

ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHOD...

ANTI-EGFRvIII ANTIBODIES AND USES THEREOF

METHODS FOR TUMOR TREATMENT USING CD3XCD20 BISPECIFIC ANTIBODY

METHODS OF TREATING PRLR POSITIVE BREAST CANCER

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific An...